Archive for November 22nd, 2010

About that MediCare waste & fraud …

November 22, 2010

About half of ObamaCare is being funded by cuts in MediCare – and about half of that is supposed to come from eliminating waste & fraud.

Yeah, right.

It’ll be fun watching the the MediCare chief report to GOP interrogators on his progress.

But, I’m still betting under on this one.

From the Christian Science Monitor …

Oversight hearings will begin in the GOP-run House in January.

One of the first oversight hearings will likely probe how the Obama administration intends to attain $500 billion in cuts to Medicare mandated by the health-care reform act.

That will involve a trip to Capitol Hill by Donald Berwick, whom Obama appointed, without Senate confirmation and over GOP objections, to head the government’s Medicare and Medicaid programs.

Republicans will no doubt ask Dr. Berwick to explain how those cuts can be made and what their effect on seniors will be.

http://www.csmonitor.com/USA/Politics/2010/1115/Health-care-reform-in-GOP-cross-hairs/(page)/2

Children’s Tylenol is back, but will Mom buy?

November 22, 2010

TakeAway:  The first children’s Tylenol products are returning to drugstore shelves after a long safety recall, and maker Johnson & Johnson now faces the tricky task of persuading parents to buy the pain reliever again. 

The company has taken a low-key approach and must walk a messaging tightrope, providing reassurance that it has fixed its problems without calling so much attention to them that safety concerns resurface.

* * * * *

Excerpted from WSJ, “Tylenol for Kids Returns to Shelves” By Jonathan Rockoff, November 18, 2010

Bottles of the grape-flavored version of children’s Tylenol have begun reappearing in pharmacies across the country half a year after several J&J over-the-counter children’s medicines were pulled because of manufacturing problems.

The recalls have cost the company hundreds of millions of dollars in lost sales and prompted a shake-up of manufacturing and management.  The quality problems included floating metal particles in the medicines and the potential for excessive concentrations of an active ingredient.

To get parents to return to Tylenol, J&J must combat not just the hit to its reputation but also the encroachment of rival brands, which have been taking over shelf space in drugstores. Cheaper private-label brands are also gaining amid the tough economy as sales of branded medicines drop.  Loyalty to Tylenol’s pain pills, a strong indication that customers will buy the product, dropped 7% in the past year, according to an annual survey in August of 35,000 Americans.  Among over-the-counter pain medicines, Tylenol ranked behind rivals Advil, Aleve and Excedrin in terms of customer loyalty after trailing only Advil in 2009.

“You don’t want to always be apologizing, because that cues the wrong response. You want to be cuing the core emotional benefits that Tylenol delivers,” said the chief executive of a company that consulted for J&J.  There are no signs in stores calling attention to the return, and packaging appears similar to the box before the recall.

Tylenol is a signature brand for J&J, which also sells prescription drugs and medical devices. The company’s swift withdrawal of the medicine during a fatal tampering episode in 1982 endeared J&J and Tylenol to generations of consumers.  Some of that goodwill persists, even after the most recent recalls.

Edit by AMW

* * * * *

Full Article:

http://online.wsj.com/article/SB10001424052748703688704575620851371476806.html


* * * * *